Mint and Dermatitis - atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis - atopic is reported as a side effect among people who take Mint (peppermint), especially for people who are female, 60+ old, also take Palbociclib, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Dermatitis - atopic when taking Mint. It is created by eHealthMe based on reports of 1,300 people who have side effects when taking Mint from the FDA, and is updated regularly.

What is Mint?

Mint has active ingredients of peppermint. eHealthMe is studying from 1,344 Mint users. Check the latest studies of Mint.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 2,008 drugs and 1,972 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

On Jul, 16, 2026

1,300 people reported to have side effects when taking Mint.
Among them, 15 people (1.15%) have Dermatitis - atopic.

Among these 15 people:

What is the gender of people who have Dermatitis - atopic when taking Mint? *

female: 100 %
male: 0.0 %

What is the age of people who have Dermatitis - atopic when taking Mint? *

What are other drugs people take besides Mint? *

Xgeva: 12 people, 80.00%
Calcium: 12 people, 80.00%
Palbociclib: 12 people, 80.00%
Diclofenac: 7 people, 46.67%
Letrozole: 4 people, 26.67%
Fulvestrant: 4 people, 26.67%
Harpagophytum: 4 people, 26.67%
Harpagophytum Procumbens: 4 people, 26.67%
Mometasone Furoate: 4 people, 26.67%
Omeprazole: 4 people, 26.67%

What are other side effects people have besides Dermatitis - atopic? *

White Blood Cell Count Decreased: 12 people, 80.00%
Joint Pain: 12 people, 80.00%
Skin Haemorrhage (bleeding into skin): 12 people, 80.00%
Back Pain: 12 people, 80.00%
Rash Erythematous (redness of the skin): 12 people, 80.00%
Psoriasis (immune-mediated disease that affects the skin): 12 people, 80.00%
Chills (felling of cold): 12 people, 80.00%
Oral Mucosal Erythema (redness of the mucous membrane of mouth): 12 people, 80.00%
Fall: 12 people, 80.00%
Nausea (feeling of having an urge to vomit): 12 people, 80.00%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 12 people, 80.00%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mint and have Dermatitis - atopic?

- Check whether Dermatitis - atopic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mint:

Mint (1,344 reports)

Browse all side effects of Mint:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis - atopic:

Dermatitis - atopic (2,008 drugs)

Browse all the conditions that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,972 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on peppermint (the active ingredients of Mint) and Mint (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.